LIPID THERAPEUTICS GmbH Novel therapies for inflammatory diseases of the digestive system
OVERVIEW
LIPID-THERAPEUTICS.COM TRAFFIC
Date Range
Date Range
Date Range
LIPID-THERAPEUTICS.COM HISTORY
SPAN
LINKS TO WEBSITE
INVESTOR IN LIFE SCIENCE TECHNOLOGIES. By investing in seasoned managers. Who translate cutting edge life science. We invest in start-ups to later stage companies. And we invest throughout Europe. We build companies creating significant commercial opportunities. We manage funds on behalf of major European private and institutional investors.
Business Development, Risk and Compliance. A Leading Asset Manager in Healthcare. A Leading Asset Manager in Healthcare. HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies. Dr Andreas Wicki, CEO.
Bcl-3-Protein Auslöser von Colitis ulcerosa? Wissenschaftler der Uni Mainz. Und des Helmholtz Zentrums München. Haben gezeigt, dass ein Überangebot des aus der Krebsforschung bekannten Proteins Bcl-3. Im Darm von Mäusen schwere Entzündungen auslöst. Auch bei Colitis-Patienten wird viel Bcl-3 gefunden, welches die Aktivierung der regulatorisch auf das Immunsystem wirkenden Tregs.
Nestlé Health Science oferuje rozwiązania z zakresu żywienia przeznaczone dla osób mających szczególne potrzeby żywieniowe wynikające z istniejących u nich chorób, problemów zdrowotnych lub specjalnej sytuacji na różnych etapach życia. Więcej informacji w sekcji o nas. Nestlé Institute of Health Sciences.
Althera, Alfare, Alfamino. Pionier in voeding en gezondheidsmanagement. Een vezelpreparaat voor medisch gebruik bij darmpassage problematiek.
Allergia alle Proteine del Latte Vaccino. Allergia alle Proteine del Latte Vaccino. Ulcere e piaghe da decubito. Nestlé Institute of Health Sciences.
WHAT DOES LIPID-THERAPEUTICS.COM LOOK LIKE?
CONTACTS
Lipid Therapeutics GmbH
Gerhard Keilhauer
Im Neuenheimer Feld 518
Heidelberg, 69120
GERMANY
11 Internet AG
Hostmaster EINSUNDEINS
Brauerstr. 48
Karlsruhe, 76135
GERMANY
LIPID-THERAPEUTICS.COM SERVER
NAME SERVERS
BROWSER IMAGE
SERVER SOFTWARE AND ENCODING
We found that this website is employing the Apache operating system.HTML TITLE
LIPID THERAPEUTICS GmbH Novel therapies for inflammatory diseases of the digestive systemDESCRIPTION
Novel therapies for inflammatory diseases of the digestive system Neue Therapien für Entzündungskrankheiten des VerdauungssystemsPARSED CONTENT
The web site lipid-therapeutics.com states the following, "Current Projects LT-02 for the treatment of Ulcerative colitis." I saw that the website also stated " Lipid Therapeutics lizensiert die Rechte an seiner neuartigen Therapie zur Behandlung der Colitis ulcerosa an Nestlé Health Science." They also said " Nestlé Health Science wird LT-02 außerhalb von Europa und Australien weltweit entwickeln und kommerzialisieren. Gegenwärtige Projekte LT-02 für die Behandlung von Colitis ulcerosa." The meta header had Colitis ulcerosa as the first optimized keyword. This keyword is followed by inflammatory bowel disease, IBD, and gut which isn't as urgent as Colitis ulcerosa. The other words lipid-therapeutics.com used was phosphatidyl-choline. inflamation is included but will not be seen by search parsers.ANALYZE SIMILAR DOMAINS
Welcome to the Bologna Biocomputing Group. Node of the BioSapiens Network of Excellence. Member of the European Computational Biology Community. Member of the Bologna Computational Biology Network. FIRB 2003-LIBI - International Laboratory of Bioinformatics. Member of the Centre of Genome Biology.
Distilled Topped Coconut Fatty Acid. Distilled Palm Kernel Fatty Acid. Distilled Topped Palm Kernel Fatty Acid. Distilled Palm Oil Fatty Acid. Distilled Palm Stearin Fatty Acid. Hydrogenated Topped Coconut Fatty Acid.
This resource is available free of charge on www. And is widely used by academics, company scientists and students around the world. Lipid Analysis and Fatty Acid Profiling. We are one of the few laboratories in the world that has been approved by both the UK MHRA.
Laboratory of Integrated Performance in Design. Open Masters and Semester projects. Technical reports, standards and patents. Interface between technology, sustainability architecture in Le Temps. Journal paper accepted to LEUKOS.